Red Cedar Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$5.49M Buy
22,889
+125
+0.5% +$28K 3.48% 8
2022
Q3
$4.18M Sell
22,764
-3
-0% -$598 2.89% 12
2022
Q2
$3.83M Buy
22,767
+7,359
+48% +$1.58M 2.59% 14
2022
Q1
$3.86M Buy
15,408
+186
+1% +$46.7K 2.33% 14
2021
Q4
$3.91M Buy
15,222
+358
+2% +$87.6K 2.23% 14
2021
Q3
$3.61M Buy
14,864
+110
+0.7% +$26.9K 2.21% 15
2021
Q2
$3.05M Sell
14,754
-63
-0.4% -$12.8K 1.92% 15
2021
Q1
$2.79M Buy
14,817
+4
+0% +$705 1.86% 17
2020
Q4
$2.44M Sell
14,813
-65
-0.4% -$9.5K 1.78% 16
2020
Q3
$1.85M Sell
14,878
-80
-0.5% -$9.9K 1.62% 16
2020
Q2
$1.45M Sell
14,958
-542
-3% -$56.3K 1.31% 23
2020
Q1
$1.39M Buy
+15,500
New +$2.01M 1.4% 21

Other funds holding HCA

Red Cedar Capital's HCA Position: Q4 2022 in Review

Red Cedar Capital increased its HCA Healthcare (HCA) stake by 0.55% in Q4 2022, buying an estimated $28K and bringing the position to 22,889 shares worth $5.49M. The position accounts for 3.48% of the portfolio, ranked #8.

Red Cedar Capital first reported a position in HCA in Q1 2020 and has held it in 12 quarters since. 961 funds tracked by Wall St. Rank hold HCA as of Q4 2022.

  • Red Cedar Capital held 22,889 shares of HCA Healthcare worth $5.49M as of Q4 2022.
  • Red Cedar Capital bought 125 HCA Healthcare shares in Q4 2022, an estimated $28K.
  • HCA Healthcare made up 3.48% of Red Cedar Capital's portfolio in Q4 2022, its #8 holding.
  • Red Cedar Capital first reported a position in HCA Healthcare in Q1 2020 and has held it in 12 quarters since.
  • 961 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2022.

Based on Red Cedar Capital's 13F filing for Q4 2022, filed 6 Feb 2023.